Haleon plc (NYSE: HLN) AI-Powered Stock Analysis
See how Haleon plc scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
HLN●NYSE
HealthcareDrug Manufacturers - Specialty & Generic
$9.79
$0.15(1.51%)
U.S. Market is Open · 13:57
Haleon plc (NYSE: HLN) AI-Powered Stock Analysis
See how Haleon plc scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerHaleon plc (NYSE: HLN) Stock Overall Grade
Haleon plc's grade for its NYSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Haleon plc's overall NYSE stock rating.
Forecast
C+Score
56/100Financial Growth
AScore
85/100Fundamental Growth
AScore
80/100Key Ratios
A+Score
94/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
BScore
63/100Haleon plc (NYSE: HLN) AI-Powered Stock Analysis
On the NYSE, HLN demonstrates Good performance with an overall Forecast Score of 56/100 (C+), reflecting weak confidence in its potential. Financial Growth (85/100, A) and Fundamental Growth (80/100, A) highlight its stability, while Key Ratios (94/100, A+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NYSE-listed stock shows competitive strength. Analyst Consensus (63/100, B) suggests High divergence in outlook.(NYSE: HLN) Component Analysis Explained
Understand the key factors behind each Haleon plc (NYSE: HLN) stock grade, including financials, comparisons, and forecasts.